Lung Cancer Rx podcast

What Do ASCO 2026 Data on NSCLC Co-mutations Mean for Practice?

0:00
31:01
Rewind 15 seconds
Fast Forward 15 seconds

Ferdinandos Skoulidis, MD, PhD, discusses data on KRAS- mutated NSCLC from ASCO 2026 with Aakash Desai, MD, MPH, Fawzi F. Abu Rous, MD, and Eric K. Singhi, MD.

More episodes from "Lung Cancer Rx"